AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 277 filers reported holding AVANOS MED INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $7 | -99.9% | 264 | -52.2% | 0.00% | – |
| Q3 2022 | $12,000 | -7.7% | 552 | +15.0% | 0.00% | – |
| Q2 2022 | $13,000 | +8.3% | 480 | +24.0% | 0.00% | – |
| Q1 2022 | $12,000 | 0.0% | 387 | +6.9% | 0.00% | – |
| Q4 2021 | $12,000 | +1100.0% | 362 | +474.6% | 0.00% | – |
| Q3 2021 | $1,000 | -50.0% | 63 | +5.0% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 60 | +5.3% | 0.00% | – |
| Q1 2021 | $2,000 | -75.0% | 57 | -68.7% | 0.00% | – |
| Q4 2020 | $8,000 | +60.0% | 182 | +15.9% | 0.00% | – |
| Q3 2020 | $5,000 | -37.5% | 157 | -44.3% | 0.00% | – |
| Q2 2020 | $8,000 | 0.0% | 282 | +0.7% | 0.00% | – |
| Q1 2020 | $8,000 | -11.1% | 280 | 0.0% | 0.00% | – |
| Q4 2019 | $9,000 | -10.0% | 280 | 0.0% | 0.00% | – |
| Q3 2019 | $10,000 | -94.2% | 280 | -92.9% | 0.00% | -100.0% |
| Q2 2019 | $171,000 | -1.2% | 3,929 | -3.1% | 0.00% | 0.0% |
| Q1 2019 | $173,000 | -1.7% | 4,056 | +3.2% | 0.00% | -33.3% |
| Q4 2018 | $176,000 | -34.6% | 3,929 | 0.0% | 0.00% | -25.0% |
| Q3 2018 | $269,000 | – | 3,929 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 2,482,743 | $113,908,000 | 6.40% |
| RGM Capital, LLC | 1,984,455 | $91,047,000 | 3.97% |
| Cove Street Capital, LLC | 204,438 | $9,380,000 | 1.66% |
| Millrace Asset Group, Inc. | 41,200 | $1,890,000 | 1.32% |
| Phocas Financial Corp. | 142,037 | $6,516,000 | 1.00% |
| Champlain Investment Partners, LLC | 3,470,935 | $159,246,000 | 0.91% |
| HEARTLAND ADVISORS INC | 231,533 | $10,623,000 | 0.76% |
| CONFLUENCE INVESTMENT MANAGEMENT LLC | 481,042 | $22,070,000 | 0.33% |
| Wakefield Asset Management LLLP | 14,653 | $672,000 | 0.28% |
| S.A. Mason LLC | 6,527 | $299,000 | 0.25% |